Received Jul 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
recurrent Breast Cancer; This is a spontaneous report received from a Consumer or other non HCP. A 76-year-old female patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 18Sep2023 as dose 1, single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure / PACS" (unspecified if ongoing); "Blood pressure / PACS" (unspecified if ongoing); "Preventive cholesterol" (unspecified if ongoing); "Breast cancer", start date: 25Feb1997 (ongoing); "pulmonary nodule", start date: 2017 (unspecified if ongoing), notes: MRI indicated 2 pulmonary nodules which necessitated a CT scan. The 2 nodules were in the right side. The 2nd in the lingula which had grown from 6 mm - 10 mm since 2017. Concomitant medication(s) included: DILTIAZEM taken for blood pressure abnormal, supraventricular extrasystoles; LOSARTAN; VALSARTAN; HCTZ; ROSUVASTATIN taken for blood cholesterol abnormal; ANASTROZOLE. Vaccination history included: moderna COVID-19 vaccine (DOSE 1, SINGLE), administration date: 12Feb2021, for Covid-19 immunization; moderna COVID-19 vaccine (DOSE 2, SINGLE), administration date: 12Mar2021, for Covid-19 immunization; moderna COVID-19 vaccine (DOSE 3 (BOOSTER), SINGLE), administration date: 22Oct2021, for Covid-19 immunization; BNT162b2 (DOSE 4 (BOOSTER), SINGLE), administration date: 30Mar2022, for Covid-19 immunization; BNT162b2;BNT162b2 omi ba.4-5 (DOSE 5 (BOOSTER), SINGLE), administration date: 09Sep2022, for Covid-19 immunization; BNT162b2;BNT162b2 omi ba.4-5 (DOSE 6 (BOOSTER), SINGLE), administration date: 16Jun2023, for Covid-19 immunization. The following information was reported: BREAST CANCER RECURRENT (medically significant) with onset 28Aug2024, outcome "unknown", described as "recurrent Breast Cancer". Clinical course: Patient have received 8 covid shots and received vaccinations from 2021-2025. The vaccination date for the 7th dose was also reported as 18Sep2023/23May2024.
Breast cancer female
Medical History/Concurrent Conditions: Blood pressure abnormal; Cholesterol total abnormal NOS; Lung nodule (MRI indicated 2 pulmonary nodules which necessitated a CT scan. The 2 nodules were in the right side. The 2nd in the lingula which had grown from 6 mm-10 mm since 2017); Premature atrial contraction
DILTIAZEM; LOSARTAN; VALSARTAN; HCTZ; ROSUVASTATIN; ANASTROZOLE